The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2026

Filed:

Jul. 16, 2020
Applicant:

Changen Therapeutics (Shanghai) Co., Ltd., Shanghai, CN;

Inventors:

Wei Qiang Gao, Shanghai, CN;

Bin MA, Shanghai, CN;

Pan Yin, Shanghai, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0775 (2010.01); A61K 35/28 (2015.01); A61P 35/00 (2006.01); C07K 14/52 (2006.01); C12N 5/10 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0668 (2013.01); A61K 35/28 (2013.01); A61P 35/00 (2018.01); C07K 14/521 (2013.01); C12N 5/0665 (2013.01); C12N 5/10 (2013.01);
Abstract

An immunotherapy method of targeted chemokine and cytokine delivery by a mesenchymal stem cell that expresses an immunostimulatory factor. The immunostimulatory factor is selected from the following group: CCL3, CCL19, CCL21, XCL1, CXCL9, OX40L, 4-1BBL, GITRL, CD40L, or a combination thereof. At a tumor site, the mesenchymal stem cell specifically attracts and activates an immune cell that kills tumor tissue, and the mesenchymal stem cell has a synergistic effect with chemokines and/or cytokines, having an immunotherapeutic effect with higher efficiency and few side effects, and a significantly enhanced ability to kill tumor tissue, especially colorectal cancer cells.


Find Patent Forward Citations

Loading…